MEAN RESIDENCE TIME OF ORAL-DRUGS UNDERGOING 1ST-PASS AND LINEAR REVERSIBLE METABOLISM

被引:10
作者
CHENG, HY [1 ]
JUSKO, WJ [1 ]
机构
[1] SUNY BUFFALO,SCH PHARM,DEPT PHARMACEUT,BUFFALO,NY 14260
关键词
ORAL ADMINISTRATION; MEAN RESIDENCE TIME; REVERSIBLE METABOLISM; 1ST-PASS METABOLISM; PHARMACOKINETICS;
D O I
10.1023/A:1018904509178
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Equations for the mean residence times in the body (MRT) and AUMC/AUC of a drug and its metabolite have been derived for an oral drug undergoing first-pass and linear reversible metabolism. The mean residence times of the drug or interconversion metabolite in the body after oral drug are described by equations which include the mean absorption time (MAT), the mean residence times of the drug or metabolite in the body after intravenous administration of the drug, the fractions of the dose entering the systemic circulation as the parent drug and metabolite, and the systemically available fractions of the drug (F(p)p) or metabolite (F(m)p). Similarly, the AUMC/AUC of the drug and metabolite after oral drug can be related to the MAT, ratios of the fraction of the dose entering the systemic circulation to the systemically available fraction, the first-time fractional conversion of each compound, and AUMC/AUC ratios after separate intravenous administration of each compound. The P(p)p and F(m)p values, in turn, are related to the first-pass availabilities of both drug and metabolite and the first-time fractional conversion fractions. The application of these equations to a dual reversible two-compartment model is illustrated by computer simulations.
引用
收藏
页码:8 / 13
页数:6
相关论文
共 19 条
[1]   MEAN RESIDENCE TIME FOR DRUGS SUBJECT TO REVERSIBLE METABOLISM [J].
AARONS, L .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (07) :565-567
[2]   EFFECTS OF 1ST-PASS METABOLISM ON METABOLITE MEAN RESIDENCE TIME DETERMINATION AFTER ORAL-ADMINISTRATION OF PARENT DRUG [J].
CHAN, KKH ;
GIBALDI, M .
PHARMACEUTICAL RESEARCH, 1990, 7 (01) :59-63
[3]   CONSTANT-RATE INTRAVENOUS-INFUSION METHODS FOR ESTIMATING STEADY-STATE VOLUMES OF DISTRIBUTION AND MEAN RESIDENCE TIMES IN THE BODY FOR DRUGS UNDERGOING REVERSIBLE METABOLISM [J].
CHENG, HY ;
JUSKO, WJ .
PHARMACEUTICAL RESEARCH, 1990, 7 (06) :628-632
[4]   MEAN INTERCONVERSION TIMES AND DISTRIBUTION RATE PARAMETERS FOR DRUGS UNDERGOING REVERSIBLE METABOLISM [J].
CHENG, HY ;
JUSKO, WJ .
PHARMACEUTICAL RESEARCH, 1990, 7 (10) :1003-1010
[5]   MEAN RESIDENCE TIMES OF MULTICOMPARTMENTAL DRUGS UNDERGOING REVERSIBLE METABOLISM [J].
CHENG, HY ;
JUSKO, WJ .
PHARMACEUTICAL RESEARCH, 1990, 7 (01) :103-107
[6]   MEAN RESIDENCE TIME THEORETICAL DEVELOPMENT, EXPERIMENTAL-DETERMINATION, AND PRACTICAL USE IN TRACER ANALYSIS [J].
COVELL, DG ;
BERMAN, M ;
DELISI, C .
MATHEMATICAL BIOSCIENCES, 1984, 72 (02) :213-244
[8]   CONCEPTS, PROPERTIES, MEASUREMENT, AND COMPUTATION OF CLEARANCE RATES OF HORMONES AND OTHER SUBSTANCES IN BIOLOGICAL-SYSTEMS [J].
DISTEFANO, JJ .
ANNALS OF BIOMEDICAL ENGINEERING, 1976, 4 (03) :302-319
[9]  
EBLING WF, 1986, J PHARM BIOPHARM, V14, P558
[10]   ON MEAN RESIDENCE TIMES IN COMPARTMENTS [J].
EISENFELD, J .
MATHEMATICAL BIOSCIENCES, 1981, 57 (3-4) :265-278